PUBLIC COMPANY
save$DXCMDEXCOM INC
$DXCM90.22+0.38%San Diego, CA, USupdated 2h ago
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
community read0 votes
pipeline
0
marketed
0
phase 3
0
catalysts ytd
7
approvals ytd
0
recalls ytd
0
Pipeline(0)
no pipeline products on record
Upcoming
Recent(90d)
view all catalysts →Insider activity
source: SEC Form 4open-market buys + sells
routine RSU / option mechanics (6)
- Mar 8, 26tax coverSAYER KEVIN R · Executive Chair32,498 sh
- Mar 8, 26tax coverBrown Michael Jon · EVP, Chief Legal Officer23,325 sh
- Mar 8, 26tax coverLeach Jacob Steven · President, CEO, and Director19,757 sh
- Mar 8, 26tax coverSylvain Jereme M · EVP, Chief Financal Officer18,950 sh
- Mar 8, 26tax coverStern Sadie · EVP, Chief HR Officer17,199 sh
- Mar 8, 26grantStern Sadie · EVP, Chief HR Officer39,019 sh
🐶 Hiring Signal
next earnings Oct 29, 2026
News
- FDA Clears First Over-the-Counter Continuous Glucose Monitor for ChildrenThe U.S. Food and Drug Administration today cleared for marketing the first over-the-counter (OTC) continuous glucose monitor (CGM) for children, Dexcom Inc.’s Stelo Glucose Biosensor System, an in…fda_press · 2mo ago
Data sources
last refreshed just now
Found something off?
comments(0)
5-min edit window · permanent after that